DREAMM13

A Phase I Study of Belantamab Mafodotin in Multiple Myeloma Participants with Normal and Impaired Hepatic Function

Near Add Your Location

Sorting 13 by

Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
  • Accepting patients
  • Show Principal Investigator
Beverly Hills Cancer Center
Beverly Hills, CA
  • Accepting patients
  • Show Principal Investigator
University of Arizona Cancer Center
Tucson, AZ
  • Accepting patients
  • Show Principal Investigator
UPMC Hillman Cancer Center
University of Pittsburgh Medical Center (UPMC)
Pittsburgh, PA
  • Accepting patients
  • Show Principal Investigator
Aurora St. Luke's Medical Center
Milwaukee, WI
  • Accepting patients
  • Show Principal Investigator
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
  • Accepting patients
  • Show Principal Investigator
Cancer Center of Kansas (Heritage Plaza)
Wichita, KS
  • Accepting patients
  • Show Principal Investigator
John Theurer Cancer Center at Hackensack University Medical Center 
Hackensack Meridian Health
Hackensack, NJ
  • Not yet accepting
  • Show Principal Investigator
Joe Arrington Cancer Research and Treatment Center
Covenant Health
Lubbock, TX
  • Not yet accepting
  • Show Principal Investigator
Baylor Charles A. Sammons Cancer Center
Baylor Scott & White Health
Dallas, TX
  • Not yet accepting
  • Show Principal Investigator

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.